[Testicular germ cell tumors late relapses]

Area of Science:

• Oncology
• Genitourinary Oncology
• Cancer Research

Context:

• Late relapses (LR) of germ cell tumors (GCT) occur >2 years post-initial treatment.
• These rare events often affect patients with advanced initial stage non-seminomatous GCT (NSGCT).
• Prognosis is poor, with a median survival of 23.9 months post-chemotherapy.

Purpose:

• To delineate the distinct clinical scenarios within late relapses of GCT.
• To outline current treatment standards for different late relapse presentations.
• To explore potential future strategies for risk stratification.

Summary:

• LR diagnosis often presents with symptoms, CT scans, or rising tumor markers.
• Two main LR groups exist: initially observed GCT (treated with first-line stage II standards) and NSGCT post-chemotherapy (primarily treated with surgery, achieving >50% long-term remission).
• Complex cases like multifocal or non-extirpable tumors necessitate combined therapeutic approaches.

Impact:

• Current surgical approaches for specific LR types yield significant long-term remission rates.
• Understanding genetic profiles may enable future identification of GCTs at risk for late relapse.
• This could lead to tailored surveillance and treatment strategies for improved patient outcomes.